← Leaderboards
Thomas Denny
Duke University
$80,103,265
Attributed
$80,103,265
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $17.4M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$80,103,265 · 5
By mechanism
N01$80,103,265 · 5
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Douglas Brock Cines$21,888,352
- Gregory D Sempowski$25,654,938
- Sampa Santra$24,353,084
- Rory Henderson$10,557,589
- Priyamvada Acharya$21,922,845
Others in their field
Other Emerging Leaders on “National Institute Of Allergy And Infectious Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Beth Baseler · Leidos Biomedical Research, Inc.$158,999,256
- Kimberly Smith · Ppd Development Lp$122,921,392
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Ted Ross · University Of Georgia$71,962,304
Research focus
National Institute Of Allergy And Infectious DiseaseLaboratoriesStandardizationReagentAcquired Immunodeficiency SyndromeProgramsVirologyEnsureContractsPerformanceImmunologySiteQuality AssuranceSamplingBiometryQuality ControlImmunologicsUnited States National Institutes Of HealthHiv VaccineDesignMethodologyPathogenAssay DevelopmentMonitor
Grant awards (33)
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$3,434,765
N01 · FY2025 · AI · contact PI
Immunology Quality Assessment (IQA) Program$1,889,645
N01 · FY2025 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core$529,176
N01 · FY2025 · AI · contact PI
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core$11,116,941
N01 · FY2024 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$3,493,120
N01 · FY2024 · AI · contact PI
Immunology Quality Assessment (IQA) Program$1,950,162
N01 · FY2024 · AI · contact PI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$824,248
N01 · FY2024 · AI · contact PI
External Quality Assurance Program Oversight Laboratory (EQAPOL)$5,036,820
N01 · FY2023 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$4,009,106
N01 · FY2023 · AI · contact PI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)$1,830,201
N01 · FY2023 · AI · contact PI
IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM$1,825,711
N01 · FY2023 · AI · contact PI
CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2$1,509,136
N01 · FY2023 · AI · contact PI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$804,081
N01 · FY2023 · AI · contact PI
External Quality Assurance Program Oversight Laboratory (EQAPOL)$4,868,722
N01 · FY2022 · AI · contact PI
CIVIC: VACCINE MANUFACTURING AND TOXICOLOGY CORE FOR SARS-CoV-2$4,000,066
N01 · FY2022 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$3,104,519
N01 · FY2022 · AI · contact PI
COVID-19: External Quality Assurance Program Oversight Laboratory (EQAPOL)$1,787,600
N01 · FY2022 · AI · contact PI
IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM$1,735,601
N01 · FY2022 · AI · contact PI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$784,546
N01 · FY2022 · AI · contact PI
External Quality Assurance Program Oversight Laboratory (EQAPOL)$4,800,982
N01 · FY2021 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$3,049,498
N01 · FY2021 · AI · contact PI
IMMUNOLOGY QUALITY ASSESSMENT (IQA) PROGRAM$1,687,067
N01 · FY2021 · AI · contact PI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$765,309
N01 · FY2021 · AI · contact PI
COVID-19: NIAID VIROLOGY QUALITY ASSURANCE (VQA)$641,460
N01 · FY2021 · AI · contact PI
COVID-19: Nonhuman Primate Core Virology Laboratory$517,714
N01 · FY2021 · AI · contact PI
EXTERNAL QUALITY ASSURANCE PROGRAM OVERSIGHT LABORATORY (EQAPOL)$4,675,225
N01 · FY2020 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$2,848,397
N01 · FY2020 · AI · contact PI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$746,698
N01 · FY2020 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA) COVID-19$668,265
N01 · FY2020 · AI · contact PI
COVID-19: Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development$573,990
N01 · FY2020 · AI · contact PI
NIAID VIROLOGY QUALITY ASSURANCE (VQA)$3,156,300
N01 · FY2019 · AI · contact PI
NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT$726,266
N01 · FY2019 · AI · contact PI
NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT$711,928
N01 · FY2018 · AI · contact PI